Ganoderma atrum polysaccharide modulates TNF-α secretion and mRNA expression in macrophages of S-180 tumor-bearing mice

被引:18
作者
Huang, Jianqin [1 ]
Nie, Qixing [1 ]
Liu, Xiaozhen [1 ]
Zhang, Shenshen [1 ]
Nie, Shaoping [1 ]
Huang, Danfei [1 ]
Wang, Sunan [2 ]
Zhu, Fan [3 ]
Xie, Mingyong [1 ]
机构
[1] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang 330047, Jiangxi, Peoples R China
[2] Niagara Coll, Canadian Food & Wine Inst, Niagara On The Lake, ON L0S 1J0, Canada
[3] Univ Auckland, Sch Chem Sci, Auckland 1, New Zealand
基金
中国国家自然科学基金;
关键词
Ganoderma atrum polysaccharide; Macrophages; Tumor necrosis factor; ACTIVATED PROTEIN-KINASE; IMMUNOMODULATING ACTIVITIES; ANTIOXIDANT ACTIVITY; SIGNALING PATHWAYS; LUCIDUM;
D O I
10.1016/j.foodhyd.2014.12.035
中图分类号
O69 [应用化学];
学科分类号
070301 [无机化学];
摘要
Previous researches focused on the chemical structure of Ganoderma atrum polysaccharide (PSG-1), and found it has antitumor and immunoregulatory activities. However, the mechanisms behind these biological activities remain unclear. The purpose of this study was to investigate the possible signaling pathways involved in the PSG-1 activated macrophage of S180 tumor-bearing mice. In vitro, PSG-1 probably stimulated macrophages resulting in an increase in phosphorylation of NF-kappa B, Akt and MAPK family proteins, which are indicative of activations of NF-kappa B pathway activation. Furthermore, the levels of TNF-alpha protein and TNF-alpha mRNA expression were significantly suppressed when macrophages were pretreated with various inhibitors, including NF-kappa B inhibitors, I kappa B inhibitors, MAPK inhibitors and PI3K/Akt inhibitors. These findings indicated the possible involvement of NF-kappa B signaling pathway in PSG-1-induced TNF-alpha secretion and mRNA expression, and provided new insights into the therapeutic potential of modulating NF-kappa B by PSG-1. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 32 条
[1]
Boh B, 2007, BIOTECHNOL ANN REV, V13, P265, DOI 10.1016/S1387-2656(07)13010-6
[2]
Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs [J].
Boh, Bojana .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2013, 8 (03) :255-287
[3]
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[4]
The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[5]
Comparative Immunomodulating Activities of Polysaccharides Isolated from Phellinus spp. on Cell-Mediated Immunity [J].
Chang, Zhi Qiang ;
Oh, Byung Chul ;
Lee, Sam Pin ;
Rhee, Man Hee ;
Park, Seung Chun .
PHYTOTHERAPY RESEARCH, 2008, 22 (10) :1396-1399
[6]
Purification, composition analysis and antioxidant activity of a polysaccharide from the fruiting bodies of Ganoderma atrum [J].
Chen, Yi ;
Xie, Ming-Yong ;
Nie, Shao-Ping ;
Li, Chang ;
Wang, Yuan-Xing .
FOOD CHEMISTRY, 2008, 107 (01) :231-241
[7]
Microwave-assisted extraction used for the isolation of total triterpenoid saponins from Ganoderma atrum [J].
Chen, Yi ;
Xie, Ming-Yong ;
Gong, Xiao-Feng .
JOURNAL OF FOOD ENGINEERING, 2007, 81 (01) :162-170
[8]
Quantification of total polysaccharides and triterpenoids in Ganoderma lucidum and Ganoderma atrum by near infrared spectroscopy and chemometrics [J].
Chen, Yi ;
Xie, Mingyong ;
Zhang, Hui ;
Wang, Yuanxing ;
Nie, Shaoping ;
Li, Chang .
FOOD CHEMISTRY, 2012, 135 (01) :268-275
[9]
Ganoderma species discrimination by dual-mode chromatographic fingerprinting: A study on stationary phase effects in hydrophilic interaction chromatography and reduction of sample misclassification rate by additional use of reversed-phase chromatography [J].
Chen, Yi ;
Bicker, Wolfgang ;
Wu, JunYan ;
Xie, Ming Yong ;
Lindner, Wolfgang .
JOURNAL OF CHROMATOGRAPHY A, 2010, 1217 (08) :1255-1265
[10]
Macrophage immunomodulatory activity of polysaccharides isolated from Glycyrrhiza uralensis fish [J].
Cheng, Anwei ;
Wan, Fachun ;
Wang, Jiaqi ;
Jin, Zhengyu ;
Xu, Xueming .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (01) :43-50